Huge drug cost disparities seen in health overhaul

by Ricardo Alonso-Zaldivar

(AP)—Consumer alert: If you or someone you know needs costly medications and you're hoping President Barack Obama's health care law will meet the need, you may be in for a surprise.

Where you live could make a huge difference in what you'll pay.

To keep premiums low, some states are allowing insurers to charge patients a large share of the cost for expensive medications for cancer and other serious conditions.

These "specialty drugs" cost thousands of dollars a month.

In California, the patient's share would be up to 30 percent. New York is doing it differently, setting flat copayments for all medications. The highest is $70.

Critics fear most states will follow California's lead.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Obama health law a good deal for states

Nov 26, 2012

(AP)—A new report says states can receive more than $9 in federal money for every dollar they spend to cover low-income residents under President Barack Obama's health care law.

Study: Health overhaul to raise claims cost 32 pct

Mar 26, 2013

(AP)—The nation's leading group of financial risk analysts says medical claims costs—the biggest driver of insurance premiums—will jump an average 32 percent for individual policies under President Barack Obama's health ...

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments